Product Description
As the information around signaling pathways and potentially drugable targets expands, there is increasing pressure to quickly probe these pathways. There is a greater need to understand the nature of protein-protein interactions within signaling pathways and to identify biomarkers of metabolic processes. Singleplex detection methods such as ELISA or Western blot assays are not suitable for rapid investigation of complex signaling pathways composed of several members. Multiplex Assays offers the ability to multiplex detection of several proteins from a single biological sample. Multiplex Assays allows for multiplexing of many types of assays thus reducing time, labor, and costs over traditional methods.
The Multiplex Assays market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Multiplex Assays market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Multiplex Assays Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Multiplex Assays market are:
Qiagen N.V.
Thermo Fisher Scientific Inc.
Luminex Corporation
Meso Scale Diagnostics, LLC.
Becton, Dickinson and Company
Randox Laboratories
Seegene Inc.
Illumina, Inc.
Abcam PLC
Bio-Rad Laboratories Inc.
Merck KGAA
Most important types of Multiplex Assays products covered in this report are:
Nucleic Acid-Based Multiplex Assays
Protein-Based Multiplex Assays
Most widely used downstream fields of Multiplex Assays market covered in this report are:
Research & Development
Diseases & Disorders
Companion Diagnostics
Other Applications
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.